Where Could Amarin be Propelled with AdCom and PDUFA Dates Approaching

[Anonymous]

Nice article on what to expect this week post Amarin's AdCom meet http://www.earningsimpact.com/Ideaz...-PDUFA-Dates-Approaching#sthash.ZlIzk8ro.dpbs

 

[Anonymous]

Read the forbes article. Sounds more like we will hear a flushing sound tomorrow.

 

[Anonymous]

Read the forbes article. Sounds more like we will hear a flushing sound tomorrow.

That article was depressing.

 

[Anonymous]

Maybe all these silly stock pumpers, including the OP, will now go away since the ADCOM voted no.


Propelled?????? More like, circling the drain.

 

[Anonymous]

Stunning how little the advisory committee knew about omega 3 and lipids...what does mixed dyslipidemia mean? Really? These were not omega 3 experts or even lipid experts as a whole, only a few, and two voted yes. So they want an outcomes study... FDA may still approve it, and like the FDA said, during the call, they can always withdraw the indication if reduce it fails.

Its AMRN's one hope.

Best story would be the shit canning of your CEO who everyone detests. That may buoy the stock. The guy has really put the company in a bad spot, a lot of eggs in one basket. What happened to the two gentleman of Eastern Indian descent who set up all your studies? Were they run out like some of your other execs by the CEO? Who were the 2 guys trying to hold things up? They were ok but clearly not as deep as they could have been.

Orange Book should be out soon too. Maybe NCE is granted as a life preserver.

KU